Select language:  
1800 620 420
Close menu

Real stories

Stories from people living with blood cancer, their family, carers, and friends; plus research and advocacy news.

Subscribe here to receive updates, including stories like these, via email. Or if you have your own blood cancer story to share, we’d love to hear from you.

Replacing ‘blunt-edged’ chemotherapy with targeted treatment

To save more lives from AML, we urgently need to look past standard chemotherapy toward new, more effective approaches to treatment. Supported by Tour de Cure, one of our inaugural Breakthrough Fellowship recipients, Dr Ashwin Unnikrishnan, is doing just that.

  • Research
Read more
Dr Ashwin Unnikrishnan - Leukaemia Foundation Breakthrough Fellowship Recipient

Uncovering the secrets behind leukaemia treatment resistance

Acute lymphoblastic leukaemia (ALL) is a type of blood cancer, which sees the body produce dangerous numbers of immature white blood cells. Supported by Tour de Cure, one of our inaugural Breakthrough Fellowship recipients, Dr Ashley Ng, is leading advanced research to improve our understanding of treatment-resistant ALL and develop new ways of beating it.

  • Research
Read more
Dr Ashley Ng - Leukaemia Foundation Breakthrough Fellowship Recipient

Giles Purbrick was diagnosed with blood cancer, days after becoming a father

>In January 2020, Giles and wife Jacqui welcomed their baby daughter into the world. But just days later, Giles was hit with a shock blood cancer diagnosis that turned everything on its head.

  • Lifestyle and living well
  • Research
Read more
Giles Purbrick and his wife

AML survivor Sophie Gray shares how complementary therapies gave her the edge

Sophie was diagnosed with AML in 2019, aged 29. She had a stem cell transplant later the same year from an unrelated donor and has been in remission ever since. After leaning on her yoga and mindfulness practice heavily through her recovery, Sophie underwent her yoga teacher training and teaches in Adelaide. In this article the Leukaemia Foundation asked Sophie some questions about her experience with complementary therapies.

  • Lifestyle and living well
  • Research
Read more
Sophie Gray using Complimentary Therapies

Professor David Joske talks to the Leukaemia Foundation about Complementary therapies

David Joske is a Clinical Haematologist at Sir Charles Gairdner Hospital in Perth Western Australia. He was Head of Department 1994 - 2012 and a Medical Co-Director 2017-2021. In this story David Joske talks to the Leukaemia Foundation about Complementary therapies.

  • Lifestyle and living well
  • Research
Read more
Professor David Joske

Lisa Smith CEO of Australian Bone Marrow Donor Registry

  • Interviews with experts
Read more
Lisa Smith, CEO - Australian Bone Marrow Donor Registry (ABMDR)